AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 782375 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous inflating pressure (CIP)
Number of subjects: 24
Study 782375 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 782375 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate with CIP
Number of subjects: 24
Study 782375 — intervention group
Group type: COMPARATOR
Intervention: Overall survival rate without CIP
Number of subjects: 24
Study 782375 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate for infants born in the hospital
Number of subjects: 24
Study 782375 — intervention group
Group type: COMPARATOR
Intervention: Overall survival rate for referred infants
Number of subjects: 24
Study 31423822 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care and electrical stimulation to wrist flexors and extensors for 30 minutes, twice a day, five days a week for three months
Number of subjects: 40
Study 31423822 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 31423822 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 40
Study 27246754 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 25
Study 27246754 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 25
Study 25329451 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 97
Study 25329451 — intervention group
Group type: COMPARATOR
Intervention: Lean control group
Number of subjects: 97
Study 21157392 — intervention group
Group type: EXPERIMENTAL
Intervention: Clay courts (CL)
Number of subjects: 6
Study 21157392 — intervention group
Group type: COMPARATOR
Intervention: Resin courts (R)
Number of subjects: 6
Study 19843803 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1.2 g and bolus plus infusion of saline
Number of subjects: 60
Study 19843803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.3 mg/kg IV bolus and 0.05 mg/kg/h infusion until the end of surgery
Number of subjects: 60
Study 19843803 — intervention group
Group type: COMPARATOR
Intervention: Control group received oral placebo capsules and bolus plus infusion of saline
Number of subjects: 60
Study 18269691 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated; DrotAA) at standard therapy (24 mug/kg per hour for 96 hours)
Number of subjects: 0
Study 18269691 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated; DrotAA) at alternative therapy (higher dose with variable infusion duration or variable infusion duration only)
Number of subjects: 0
Study 18269691 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (DrotAA)
Number of subjects: 0
Study 18269691 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative therapy (DrotAA)
Number of subjects: 0
Study 18269691 — intervention group
Group type: EXPERIMENTAL
Intervention: DrotAA therapy
Number of subjects: 0
Study 15238033 — intervention group
Group type: EXPERIMENTAL
Intervention: Melody cues
Number of subjects: 0
Study 15238033 — intervention group
Group type: EXPERIMENTAL
Intervention: Title cues
Number of subjects: 0
Study 15238033 — intervention group
Group type: EXPERIMENTAL
Intervention: FOK ratings
Number of subjects: 0
Study 15238033 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of real titles
Number of subjects: 0
Study 11679387 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured personal care intervention
Number of subjects: 874
Study 11679387 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin usage in intervention group
Number of subjects: 874
Study 11679387 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow up consultations arranged by intervention doctors
Number of subjects: 874
Study 11679387 — intervention group
Group type: EXPERIMENTAL
Intervention: Referrals to diabetes clinics by intervention doctors
Number of subjects: 874
Study 11679387 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting by intervention doctors
Number of subjects: 874
Study 11679387 — intervention group
Group type: COMPARATOR
Intervention: Overall mortality and predefined non-fatal outcomes
Number of subjects: 874
Study 9205997 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferruginous body concentrations analysis
Number of subjects: 55
Study 9205997 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of uncoated asbestos fibers
Number of subjects: 55
Study 9205997 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy analysis
Number of subjects: 55
Study 9205997 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 55
Study 8262653 — intervention group
Group type: EXPERIMENTAL
Intervention: HibCP-TT vaccination in group A (6 and 7 months)
Number of subjects: 144
Study 8262653 — intervention group
Group type: EXPERIMENTAL
Intervention: HibCP-TT vaccination in group B (5 and 6 months)
Number of subjects: 144
Study 8262653 — intervention group
Group type: EXPERIMENTAL
Intervention: HibCP-TT vaccination in group C (4 and 5 months)
Number of subjects: 144
Study 3553986 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange therapy
Number of subjects: 29
Study 3553986 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study 30069942 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic Electrical Muscle Stimulation (EMS)
Number of subjects: 29
Study 27517958 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein breakfast (PRO; 350 kcal; 39 g CHO, 30 g PRO, 8 g fat)
Number of subjects: 24
Study 27517958 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein breakfast (PRO)
Number of subjects: 24
Study 27517958 — intervention group
Group type: COMPARATOR
Intervention: Breakfast skipping (SKP; no breakfast)
Number of subjects: 24
Study 27517958 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate breakfast (CHO; 351 kcal; 59 g CHO, 10 g PRO, 8 g fat)
Number of subjects: 24
Study 24717366 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation from ages 6 to 12 months
Number of subjects: 1123
Study 24717366 — intervention group
Group type: COMPARATOR
Intervention: No added iron (formula with iron/powdered cow milk, vitamins without iron)
Number of subjects: 1123
Study 21927920 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 14 mg
Number of subjects: 226
Study 21927920 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 226
Study 21927920 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 100 mg
Number of subjects: 226
Study 21927920 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (all doses)
Number of subjects: 226
Study 21927920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study 21930490 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1002
Study 21930490 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 1002
Study 21930490 — intervention group
Group type: COMPARATOR
Intervention: Side branch occlusion (EES vs PES)
Number of subjects: 1002
Study 18160925 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular acupuncture
Number of subjects: 144
Study 18160925 — intervention group
Group type: EXPERIMENTAL
Intervention: Periosteal acupuncture
Number of subjects: 144
Study 18160925 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study 16317360 — intervention group
Group type: EXPERIMENTAL
Intervention: Femostop
Number of subjects: 306
Study 16317360 — intervention group
Group type: EXPERIMENTAL
Intervention: C-clamp
Number of subjects: 306
Study 16317360 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual compression
Number of subjects: 306
Study 16317360 — intervention group
Group type: EXPERIMENTAL
Intervention: Not receiving eptifibatide (Integrilin)
Number of subjects: 306
Study 16317360 — intervention group
Group type: EXPERIMENTAL
Intervention: No VC prior to femoral sheath removal
Number of subjects: 306
Study 12534029 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 mg of betamethasone (12 mg every 24 hours)
Number of subjects: 118
Study 12534029 — intervention group
Group type: COMPARATOR
Intervention: No antenatal corticosteroids (control group)
Number of subjects: 118
Study 7900523 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (maximum 800 micrograms)
Number of subjects: 156
Study 7900523 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of oxytocin
Number of subjects: 156
Study 7900523 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 156
Study 2666476 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenge sucrose drink (2 gm/kg body weight)
Number of subjects: 12
Study 2666476 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink sweetened with aspartame
Number of subjects: 12
Study 23950 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-hydroxycholecalciferol (25-HCC) 150 microgram/day for 20 days
Number of subjects: 20
Study 23950 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 150 microgram/day for 20 days
Number of subjects: 20
Study 23950 — intervention group
Group type: COMPARATOR
Intervention: 25-hydroxycholecalciferol (25-HCC) 75 microgram/day for 20 days (Control Group)
Number of subjects: 20
Study 30935673 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST intervention (physiotherapist-delivered physical and psychological intervention)
Number of subjects: 0
Study 30935673 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST intervention
Number of subjects: 0
Study 28836381 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue cleaning with mouthwash
Number of subjects: 12
Study 28836381 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue cleaning with mouth moisturising gel
Number of subjects: 12
Study 28836381 — intervention group
Group type: COMPARATOR
Intervention: Tongue cleaning with water
Number of subjects: 12
Study 28836381 — intervention group
Group type: COMPARATOR
Intervention: No tongue cleaning (negative control)
Number of subjects: 12
Study 26864365 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily breakfast (≥700 kcal before 1100)
Number of subjects: 23
Study 26864365 — intervention group
Group type: COMPARATOR
Intervention: Extended fasting (0 kcal until 1200)
Number of subjects: 23
Study 22325573 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based analysis of hemisphere growth
Number of subjects: 12
Study 22325573 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based analysis of ventricle volume
Number of subjects: 12
Study 21765272 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal physical therapy program plus deep-water running
Number of subjects: 46
Study 21765272 — intervention group
Group type: COMPARATOR
Intervention: Multimodal physical therapy program alone
Number of subjects: 46
Study 18842948 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling (CT decreased by 0.5 degrees C)
Number of subjects: 14
Study 18842948 — intervention group
Group type: EXPERIMENTAL
Intervention: Isothermic (CT remained unchanged)
Number of subjects: 14
Study 18842948 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral (control)
Number of subjects: 14
Study 17095378 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified open technique preserving the superficial skin nerves
Number of subjects: 42
Study 17095378 — intervention group
Group type: COMPARATOR
Intervention: Standard open carpal tunnel decompression without preservation of superficial nerve branches
Number of subjects: 42
Study 17095378 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 42
Study 15292547 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine cream
Number of subjects: 15
Study 15292547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 11742706 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine (G+V) 1200 mg/m(2) plus 30 mg/m(2) on days 1 and 8 every 3 weeks
Number of subjects: 120
Study 11742706 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine (V) 30 mg/m(2) on days 1 and 8 every 3 weeks
Number of subjects: 120
Study 11742706 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine (G+V)
Number of subjects: 120
Study 11742706 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine (V)
Number of subjects: 120
Study 9508188 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin plus Ftorafur (MMC-FT)
Number of subjects: 85
Study 9508188 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin alone (MMC)
Number of subjects: 85
Study 7995064 — intervention group
Group type: EXPERIMENTAL
Intervention: Healon GV
Number of subjects: 35
Study 7995064 — intervention group
Group type: COMPARATOR
Intervention: Healon
Number of subjects: 35
Study 2567755 — intervention group
Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin
Number of subjects: 200
Study 2567755 — intervention group
Group type: COMPARATOR
Intervention: cephazolin
Number of subjects: 200
Study 31843704 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental methacholine challenge
Number of subjects: 19
Study 31843704 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus methacholine challenge
Number of subjects: 19
Study 29677302 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterosacral ligament suspension (ULS)
Number of subjects: 285
Study 29677302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous ligament fixation (SSLF)
Number of subjects: 285
Study 29677302 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative behavioral therapy and pelvic floor muscle training (BPMT)
Number of subjects: 285
Study 29677302 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 285
Study 29677302 — intervention group
Group type: EXPERIMENTAL
Intervention: BPMT
Number of subjects: 285
Study 28173827 — intervention group
Group type: EXPERIMENTAL
Intervention: iSOLVE intervention
Number of subjects: 560
Study 25971686 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with FM 85®
Number of subjects: 38
Study 25971686 — intervention group
Group type: COMPARATOR
Intervention: Human milk only (Control)
Number of subjects: 38
Study 23948623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-case-management program
Number of subjects: 36
Study 23948623 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study 21531114 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesives (2-octyl)
Number of subjects: 75
Study 21531114 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesives (n-butyl-2)
Number of subjects: 75
Study 21531114 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 75
Study 21531114 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular suturing
Number of subjects: 75
Study 21531114 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 75
Study 19543680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training program
Number of subjects: 316
Study 19543680 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 316
Study 17043070 — intervention group
Group type: EXPERIMENTAL
Intervention: High power output (45 W), short application time (20 s)
Number of subjects: 90
Study 17043070 — intervention group
Group type: COMPARATOR
Intervention: Low power output (30 W), long application time (120 s)
Number of subjects: 90
Study 12774864 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 59
Study 12774864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 10647316 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation plus soft tissue therapy
Number of subjects: 75
Study 10647316 — intervention group
Group type: COMPARATOR
Intervention: Soft tissue therapy plus low-power laser therapy
Number of subjects: 75
Study 9313125 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 95
Study 9313125 — intervention group
Group type: COMPARATOR
Intervention: Control (no fibrin sealant)
Number of subjects: 95
Study 8148680 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini flow meter
Number of subjects: 12
Study 8148680 — intervention group
Group type: COMPARATOR
Intervention: Spirometer
Number of subjects: 12
Study 3225688 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 0
Study 3225688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31858186 — intervention group
Group type: EXPERIMENTAL
Intervention: Praliciguat 40 mg once daily for days 1-14
Number of subjects: 26
Study 31858186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 29289729 — intervention group
Group type: COMPARATOR
Intervention: ART/high-viscosity glass-ionomer cement (HVGIC) for single-surface restorations
Number of subjects: 0
Study 29289729 — intervention group
Group type: COMPARATOR
Intervention: ART/high-viscosity glass-ionomer cement (HVGIC) for multiple-surface restorations
Number of subjects: 0
Study 29289729 — intervention group
Group type: COMPARATOR
Intervention: Amalgam for restorations
Number of subjects: 0
Study 29289729 — intervention group
Group type: EXPERIMENTAL
Intervention: ART/high-viscosity glass-ionomer cement (HVGIC)
Number of subjects: 0
Study 27192696 — intervention group
Group type: EXPERIMENTAL
Intervention: D3
Number of subjects: 38
Study 27192696 — intervention group
Group type: COMPARATOR
Intervention: D2
Number of subjects: 38
Study 25668198 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (1 mg/m²/day) for 4 years
Number of subjects: 141
Study 25668198 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (1 mg/m²/day) for 9 years
Number of subjects: 141
Study 25668198 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (1 mg/m²/day) during adolescence
Number of subjects: 141
Study 25668198 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Tanner stages
Number of subjects: 141
Study 23000324 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAS (mechanical chest-compression device)
Number of subjects: 25
Study 20513828 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based BUP
Number of subjects: 93
Study 20513828 — intervention group
Group type: COMPARATOR
Intervention: Referred treatment
Number of subjects: 93
Study 18211533 — intervention group
Group type: EXPERIMENTAL
Intervention: TPM with a log-transformed EQ-5D index
Number of subjects: 0
Study 18211533 — intervention group
Group type: EXPERIMENTAL
Intervention: LCM
Number of subjects: 0
Study 18211533 — intervention group
Group type: COMPARATOR
Intervention: CLAD
Number of subjects: 0
Study 18211533 — intervention group
Group type: COMPARATOR
Intervention: OLS and standard TPM
Number of subjects: 0
Study 16884345 — intervention group
Group type: EXPERIMENTAL
Intervention: Single or repeated doses of kudzu extract
Number of subjects: 0
Study 16884345 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated doses of kudzu extract
Number of subjects: 0
Study 12579591 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric muscle strength measurement in patients with knee OA
Number of subjects: 113
Study 12579591 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability of isometric muscle strength measurement
Number of subjects: 113
Study 12579591 — intervention group
Group type: EXPERIMENTAL
Intervention: Random measurement error analysis
Number of subjects: 113
Study 12579591 — intervention group
Group type: COMPARATOR
Intervention: Comparison with normative data
Number of subjects: 113
Study 11503796 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (750 mug per dose)
Number of subjects: 2000
Study 11503796 — intervention group
Group type: COMPARATOR
Intervention: Ethinyloestradiol (100 mug) + Levonorgestrel (500 mug) combination
Number of subjects: 2000
Study 11503796 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2000
Study 9365449 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.25% 4-7 mL/h) and morphine (0.16-0.28 mg/h) for 18 h before and during the operation
Number of subjects: 60
Study 9365449 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline (4-7 mL/h) and oral or intramuscular morphine
Number of subjects: 60
Study 9365449 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine and morphine
Number of subjects: 60
Study 9365449 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline and oral or intramuscular morphine
Number of subjects: 60
Study 1300984 — intervention group
Group type: EXPERIMENTAL
Intervention: rHu-EPO treatment
Number of subjects: 14
Study 1300984 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 14
Study 3465056 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of lidocaine
Number of subjects: 0
Study 3465056 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injection of saline
Number of subjects: 0
Study 3465056 — intervention group
Group type: COMPARATOR
Intervention: Both lidocaine and saline injections
Number of subjects: 0
Study 3465056 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients
Number of subjects: 0
Study 3465056 — intervention group
Group type: COMPARATOR
Intervention: Referents
Number of subjects: 0
Study 28967181 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 390
Study 28967181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study 27782829 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate skin-to-skin contact (SSC)
Number of subjects: 300
Study 27782829 — intervention group
Group type: EXPERIMENTAL
Intervention: Early skin-to-skin contact (SSC)
Number of subjects: 300
Study 25008880 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose BTX-A (6 U/kg) in group B1 (n=55)
Number of subjects: 256
Study 25008880 — intervention group
Group type: COMPARATOR
Intervention: Low-dose BTX-A (3 U/kg) in group B2 (n=54)
Number of subjects: 256
Study 25008880 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose BTX-A (6 U/kg) in group A1 (n=73)
Number of subjects: 256
Study 25008880 — intervention group
Group type: COMPARATOR
Intervention: Low-dose BTX-A (3 U/kg) in group A2 (n=74)
Number of subjects: 256
Study 23673865 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin administration
Number of subjects: 26